Arkolith/Insider Trading/MDLN/Form 4

Golwas Douglas P

Chief Commercial OfficerMedline Inc. (MDLN) · full profile →Form 4 · filed Mar 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Grant(A)26K—$026K
Dec 16, 2025Grant(A)466K——466K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Grant(A)463K——463K
Dec 16, 2025Grant(A)213K——213K
Dec 16, 2025Grant(A)149K——149K
Dec 16, 2025Grant(A)949K——949K
Dec 16, 2025Grant(A)466K——466K
Dec 16, 2025Grant(A)158K——158K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096774) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML